PF-5274857

Catalog No.S2777 Batch:S277750

Print

Technical Data

Formula

C20H25ClN4O3S
Molecular Weight 436.96 CAS No. 1373615-35-0
Solubility (25°C)* In vitro DMSO 93 mg/mL (212.83 mM)
Water 93 mg/mL (212.83 mM)
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
Saline
30.0mg/ml Taking the 1 mL working solution as an example, add 30 mg of this product to 1 ml of physiological saline (0.9% NaCL solution), mix evenly to make it clear, The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can penetrate the blood–brain barrier.
Targets
Smoothened [1] Smoothened [1]
4.6 nM(Ki) 5.8 nM
In vitro PF-5274857 completely inhibits Shh-induced Hh pathway activity with IC50 of 2.7 nM measured by the transcriptional activity of Smo downstream gene Gli1 in MEF cells. The μ-opioid receptor is weakly inhibited by PF-5274857 with a dissociation constant of 36 μM subsequently determined in a functional assay. [1]
In vivo PF-5274857 shows significant dose-dependent tumor growth inhibition (TGI) and induces tumor regression at high doses(>10 mg/kg)., PF-5274857 downregulates Gli1, Gli2, Ptch1, and Ptch2 gene expression levels to various degrees with maximal effects being achieved between 6 and 12 hours post-dose (Gli1 is the most sensitive gene), whereas PF-5274857 has little effect on Smo levels. In skin tissue, downregulation of Gli1 and Gli2 is also observed with a similar time course by PF-5274857. The model-derived drug concentration for half maximal inhibition of the tumor Gli1 mRNA production rate (IC50) by PF-5274857 is determined to be 8.9 nM in the Ptch+/−p53+/− medulloblastoma allograft mice, which mathematically corresponds to tumor regression of 119% TGI after 6 days of plasma exposure at this concentration. In the Ptch+/−p53−/− medulloblastoma allograft mice, the IC50 value is estimated to be 3.5 nM, consistent with the Ptch+/−p53+/− results. PF-5274857 is also able to cross the blood–brain barrier in rats within 4 hours post-dose. [1]

Protocol (from reference)

Kinase Assay:[1]
  • Biochemical assays

    HEK293 cells overexpressing human Smo (amino acids 181-787) are grown in Dulbecco's Modified Eagle's Media (DMEM) supplemented with 10% FBS, Pen–Strep, and 0.1 mg/mL hygromycin to 90% confluence. After washing with cold Dulbecco's PBS, the cell pellet is resuspended in membrane preparation buffer (50 mM Tris-HCl, pH 7.5, 250 mM sucrose with Roche complete protease cocktail) and homogenized. The homogenate is centrifuged and the cell pellet is resuspended in assay buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 25 mM MgCl2, 1 mM EDTA, and 0.1% protease-free bovine serum albumin) and homogenized in a glass tissue grinder. Total protein in the membrane preparation containing Smo is determined using the Pierce BCA protein assay. For the competitive binding assay, 100 μL of assay buffer is added to a 96-well GF/B filter plate for 10 minutes to pre-wet the filter and then removed. The following reagents are then added: 20 μL of assay buffer, 10 μL serial dilutions of compound, 20 μL of 3H-Smo antagonist (3 nM final concentration), and 50 μL of membrane preparation (40 μg total protein). The plates are incubated at room temperature for 2 hours, then washed and vacuum dried. The plates are then dried for 1 hour in a 60°C oven before the addition of 45 μL of Microscint 20 and incubated at room temperature for 30 minutes to 1 hour, then counted in a TopCount scintillation counter. The data are analyzed using GraphPad Prism software.
Cell Assay:[1]
  • Cell lines

    Gli-Luc/MEF cells

  • Concentrations

    50 pM- 3 μM

  • Incubation Time

    48 hours

  • Method

    Gli-Luc/MEF cells are grown in the knockout DMEM supplemented with 10% heat-inactive FBS, 2 mM l-glutamine, and 0.55 mM β-mercaptoethanol until 90% confluence. On day 1, cells are trypsinized and seeded into white 384-well plates in 20 μL per well of OptiMEM media that is supplemented with 1% heat-inactive FBS and 1 mM sodium pyruvate at a concentration of 7,500 cells per well. Plates are incubated at 37 °C and 5% CO2 overnight. On day 2, PF-5274857 is added to the cells at a final concentration ranging from 3 μM to 50 pM at a 3-fold serial dilution followed by addition of recombinant mouse Sonic Hedgehog to a final concentration of 2 μg/mL. The cells are incubated with PF-5274857 and Shh for 48 hours at 37 °C and 5% CO2. Luciferase assays are conducted on day 4 using the Bright-Glo Luciferase Assay System. Briefly, Bright-Glo luciferase reagent (25 μL) is added to each well of the 384-well plate containing media. Plates are kept at room temperature for 5 minutes and then read on a Luminescence plate reader. The IC50 value of PF-5274857 is calculated.
Animal Study:[1]
  • Animal Models

    SCID-beige mice bearing primary Ptch+/−p53+/− or Ptch+/−p53−/− medulloblastoma tumor

  • Dosages

    ~30 mg/kg

  • Administration

    Oral administration

Selleck's PF-5274857 has been cited by 3 publications

Establishment and characterization of immortalized sweat gland myoepithelial cells [ Sci Rep, 2022, 12(1):7] PubMed: 34997030
A high level of KLF12 causes folic acid-resistant neural tube defects by activating the Shh signalling pathway in mice [ Biol Reprod, 2021, ioab111] PubMed: 34104947
A novel human colon signet-ring cell carcinoma organoid line: establishment, characterization and application [ Carcinogenesis, 2020, 41(7):993-1004] PubMed: 31740922

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.